Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma

BACKGROUND: Response remains an important endpoint in clinical cancer trials. However, the prognostic utility of best tumor response in metastatic renal cell carcinoma (mRCC) remains vague. OBJECTIVE: To define the prognostic relevance of the depth of remission in mRCC DESIGN, SETTING, AND PARTICIPA...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur Urol
Main Authors: Grünwald, Viktor, McKay, Rana R., Krajewski, Katherine M., Kalanovic, Daniel, Lin, Xun, Perkins, Julia J., Simantov, Ronit, Choueiri, Toni K.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570832/
https://ncbi.nlm.nih.gov/pubmed/25577718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.12.036
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki